HQL
abrdn Life Sciences Investors
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 40-17G | 9/24/2026 | View on SEC |
| NPORT-P | 8/28/2026 | View on SEC |
| N-PX | 8/21/2026 | View on SEC |
| 4 | 7/20/2026 | View on SEC |
| 3 | 6/11/2026 | View on SEC |
| N-CSRS | 6/8/2026 | View on SEC |
| NPORT-P | 5/29/2026 | View on SEC |
| DEF 14A | 4/7/2026 | View on SEC |
| SCHEDULE 13G/A | 3/6/2026 | View on SEC |
| NPORT-P | 2/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HQL |
| Company Name | abrdn Life Sciences Investors |
| CIK | 884121 |
| Exchange | NYSE |
| Entity Type | other |
| Fiscal Year End | 0930 |
| State of Incorporation | MA |
| Phone | 6177728515 |